Aurora Nutrascience Inc. – Trademark Portfolio
Entity Type: 03
Aurora Nutrascience Inc. holds 51 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 49 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 21 trademarks are registered and 10 are pending. Notable registered marks include KREO, C-BUSTER, EXOFLEX+, MEGA-PACK+, and MICRO-PACK+. The owner is based in Concord, Ontario.
86 Moyal Ct.
Concord, Ontario L4K4R8 , CA
Showing of trademarks Trademarks
Trademark Classifications
Aurora Nutrascience Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Aurora Nutrascience Inc. have?
Aurora Nutrascience Inc. has 51 U.S. trademarks filed with the USPTO. Of these, 21 registered, 10 pending, 20 abandoned.
What trademark classes does Aurora Nutrascience Inc. file in?
Aurora Nutrascience Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Aurora Nutrascience Inc.'s most well-known trademarks?
Aurora Nutrascience Inc.'s registered trademark portfolio includes well-known marks such as KREO, C-BUSTER, EXOFLEX+, MEGA-PACK+, and MICRO-PACK+. These are among 21 currently registered trademarks in the portfolio.
What is Aurora Nutrascience Inc.'s trademark registration success rate?
Aurora Nutrascience Inc. has a 51% trademark registration rate, with 21 out of 41 resolved applications resulting in successful registration. Currently, 10 applications are pending review.